ReP USP - Resultado da busca

Artigo de periodico
Evidence for the involvement of matrix metalloproteinases in the cardiovascular effects produced by nicotine (2010)
Jacob-Ferreira, Anna Laura Bechara; Palei, Ana Carolina Taveiros; Izidoro-Toledo, Tatiane de Carvalho; Gerlach, Raquel Fernanda; Tanus-Santos, José Eduardo; Cáu, Stêfany Bruno de Assis; Moreno Junior, Heitor; Martinez, Márcio Luís Lombardi
Source: European Journal of Pharmacology. Unidades: FORP, FMRP
Subjects: METALOPROTEINASES, ENDOTÉLIO VASCULAR, FUMO (EFEITOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JACOB-FERREIRA, Anna Laura Bechara et al. Evidence for the involvement of matrix metalloproteinases in the cardiovascular effects produced by nicotine. European Journal of Pharmacology, v. 627, n. 1-3, p. 216-222, 2010Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2009.10.057. Acesso em: 09 ago. 2024.
APA
Jacob-Ferreira, A. L. B., Palei, A. C. T., Izidoro-Toledo, T. de C., Gerlach, R. F., Tanus-Santos, J. E., Cáu, S. B. de A., et al. (2010). Evidence for the involvement of matrix metalloproteinases in the cardiovascular effects produced by nicotine. European Journal of Pharmacology, 627( 1-3), 216-222. doi:10.1016/j.ejphar.2009.10.057
NLM
Jacob-Ferreira ALB, Palei ACT, Izidoro-Toledo T de C, Gerlach RF, Tanus-Santos JE, Cáu SB de A, Moreno Junior H, Martinez MLL. Evidence for the involvement of matrix metalloproteinases in the cardiovascular effects produced by nicotine [Internet]. European Journal of Pharmacology. 2010 ; 627( 1-3): 216-222.[citado 2024 ago. 09 ] Available from: https://doi.org/10.1016/j.ejphar.2009.10.057
Vancouver
Jacob-Ferreira ALB, Palei ACT, Izidoro-Toledo T de C, Gerlach RF, Tanus-Santos JE, Cáu SB de A, Moreno Junior H, Martinez MLL. Evidence for the involvement of matrix metalloproteinases in the cardiovascular effects produced by nicotine [Internet]. European Journal of Pharmacology. 2010 ; 627( 1-3): 216-222.[citado 2024 ago. 09 ] Available from: https://doi.org/10.1016/j.ejphar.2009.10.057
Artigo de periodico
Isoflavone genistein inhibits the angiotensin-converting enzyme and alters the vascular responses to angiotensin I and bradykinin (2009)
Montenegro, Marcelo Freitas; Pessa, Lisandra R.; Santos, José Eduardo Tanus dos
Source: European Journal of Pharmacology. Unidade: FMRP
Subjects: ANGIOTENSINA II, SISTEMA CARDIOVASCULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MONTENEGRO, Marcelo Freitas e PESSA, Lisandra R. e SANTOS, José Eduardo Tanus dos. Isoflavone genistein inhibits the angiotensin-converting enzyme and alters the vascular responses to angiotensin I and bradykinin. European Journal of Pharmacology, v. 607, n. 1/3, p. 173-177, 2009Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2009.02.015. Acesso em: 09 ago. 2024.
APA
Montenegro, M. F., Pessa, L. R., & Santos, J. E. T. dos. (2009). Isoflavone genistein inhibits the angiotensin-converting enzyme and alters the vascular responses to angiotensin I and bradykinin. European Journal of Pharmacology, 607( 1/3), 173-177. doi:10.1016/j.ejphar.2009.02.015
NLM
Montenegro MF, Pessa LR, Santos JET dos. Isoflavone genistein inhibits the angiotensin-converting enzyme and alters the vascular responses to angiotensin I and bradykinin [Internet]. European Journal of Pharmacology. 2009 ; 607( 1/3): 173-177.[citado 2024 ago. 09 ] Available from: https://doi.org/10.1016/j.ejphar.2009.02.015
Vancouver
Montenegro MF, Pessa LR, Santos JET dos. Isoflavone genistein inhibits the angiotensin-converting enzyme and alters the vascular responses to angiotensin I and bradykinin [Internet]. European Journal of Pharmacology. 2009 ; 607( 1/3): 173-177.[citado 2024 ago. 09 ] Available from: https://doi.org/10.1016/j.ejphar.2009.02.015
Artigo de periodico
Hemodynamic effects of combined sildenafil and L-arginine during acute pulmonary embolism-induced pulmonary hypertension (2005)
Souza-Silva, Allethea R.; Dias Junior, Carlos A.; Uzuelli, Juliana A.; Moreno Junior, Heitor; Evora, Paulo R.; Tanus-Santos, Jose E.
Source: European Journal of Pharmacology. Unidade: FMRP
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA-SILVA, Allethea R. et al. Hemodynamic effects of combined sildenafil and L-arginine during acute pulmonary embolism-induced pulmonary hypertension. European Journal of Pharmacology, v. 524, p. 126-131, 2005Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2005.09.022. Acesso em: 09 ago. 2024.
APA
Souza-Silva, A. R., Dias Junior, C. A., Uzuelli, J. A., Moreno Junior, H., Evora, P. R., & Tanus-Santos, J. E. (2005). Hemodynamic effects of combined sildenafil and L-arginine during acute pulmonary embolism-induced pulmonary hypertension. European Journal of Pharmacology, 524, 126-131. doi:10.1016/j.ejphar.2005.09.022
NLM
Souza-Silva AR, Dias Junior CA, Uzuelli JA, Moreno Junior H, Evora PR, Tanus-Santos JE. Hemodynamic effects of combined sildenafil and L-arginine during acute pulmonary embolism-induced pulmonary hypertension [Internet]. European Journal of Pharmacology. 2005 ; 524 126-131.[citado 2024 ago. 09 ] Available from: https://doi.org/10.1016/j.ejphar.2005.09.022
Vancouver
Souza-Silva AR, Dias Junior CA, Uzuelli JA, Moreno Junior H, Evora PR, Tanus-Santos JE. Hemodynamic effects of combined sildenafil and L-arginine during acute pulmonary embolism-induced pulmonary hypertension [Internet]. European Journal of Pharmacology. 2005 ; 524 126-131.[citado 2024 ago. 09 ] Available from: https://doi.org/10.1016/j.ejphar.2005.09.022

USP Schools

ReP

Filtros

Authors

Subjects

Indexado em